Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

449 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erdheim-Chester disease.
Haroche J, Arnaud L, Cohen-Aubart F, Hervier B, Charlotte F, Emile JF, Amoura Z. Haroche J, et al. Among authors: emile jf. Curr Rheumatol Rep. 2014 Apr;16(4):412. doi: 10.1007/s11926-014-0412-0. Curr Rheumatol Rep. 2014. PMID: 24532298 Review.
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses.
Haroche J, Charlotte F, Arnaud L, von Deimling A, Hélias-Rodzewicz Z, Hervier B, Cohen-Aubart F, Launay D, Lesot A, Mokhtari K, Canioni D, Galmiche L, Rose C, Schmalzing M, Croockewit S, Kambouchner M, Copin MC, Fraitag S, Sahm F, Brousse N, Amoura Z, Donadieu J, Emile JF. Haroche J, et al. Among authors: emile jf. Blood. 2012 Sep 27;120(13):2700-3. doi: 10.1182/blood-2012-05-430140. Epub 2012 Aug 9. Blood. 2012. PMID: 22879539 Free article.
BRAF mutations in Erdheim-Chester disease.
Emile JF, Charlotte F, Amoura Z, Haroche J. Emile JF, et al. J Clin Oncol. 2013 Jan 20;31(3):398. doi: 10.1200/JCO.2012.46.9676. Epub 2012 Dec 17. J Clin Oncol. 2013. PMID: 23248255 No abstract available.
Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation.
Haroche J, Cohen-Aubart F, Emile JF, Arnaud L, Maksud P, Charlotte F, Cluzel P, Drier A, Hervier B, Benameur N, Besnard S, Donadieu J, Amoura Z. Haroche J, et al. Among authors: emile jf. Blood. 2013 Feb 28;121(9):1495-500. doi: 10.1182/blood-2012-07-446286. Epub 2012 Dec 20. Blood. 2013. PMID: 23258922 Free article.
Erdheim-Chester disease.
Haroche J, Arnaud L, Cohen-Aubart F, Hervier B, Charlotte F, Emile JF, Amoura Z. Haroche J, et al. Among authors: emile jf. Rheum Dis Clin North Am. 2013 May;39(2):299-311. doi: 10.1016/j.rdc.2013.02.011. Epub 2013 Mar 14. Rheum Dis Clin North Am. 2013. PMID: 23597965 Review.
Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation.
Hervier B, Haroche J, Arnaud L, Charlotte F, Donadieu J, Néel A, Lifermann F, Villabona C, Graffin B, Hermine O, Rigolet A, Roubille C, Hachulla E, Carmoi T, Bézier M, Meignin V, Conrad M, Marie L, Kostrzewa E, Michot JM, Barete S, Taly V, Cury K, Emile JF, Amoura Z; French Histiocytoses Study Group. Hervier B, et al. Among authors: emile jf. Blood. 2014 Aug 14;124(7):1119-26. doi: 10.1182/blood-2013-12-543793. Epub 2014 Jun 3. Blood. 2014. PMID: 24894769 Free article.
Recurrent RAS and PIK3CA mutations in Erdheim-Chester disease.
Emile JF, Diamond EL, Hélias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Hyman DM, Kim E, Rampal R, Patel M, Ganzel C, Aumann S, Faucher G, Le Gall C, Leroy K, Colombat M, Kahn JE, Trad S, Nizard P, Donadieu J, Taly V, Amoura Z, Abdel-Wahab O, Haroche J. Emile JF, et al. Blood. 2014 Nov 6;124(19):3016-9. doi: 10.1182/blood-2014-04-570937. Epub 2014 Aug 22. Blood. 2014. PMID: 25150293 Free PMC article.
Marked efficacy of vemurafenib in suprasellar Erdheim-Chester disease.
Cohen-Aubart F, Emile JF, Maksud P, Galanaud D, Idbaih A, Chauvet D, Amar Y, Benameur N, Amoura Z, Haroche J. Cohen-Aubart F, et al. Among authors: emile jf. Neurology. 2014 Sep 30;83(14):1294-6. doi: 10.1212/WNL.0000000000000832. Epub 2014 Aug 29. Neurology. 2014. PMID: 25171932 No abstract available.
Dramatic response of a BRAF V600E-mutated primary CNS histiocytic sarcoma to vemurafenib.
Idbaih A, Mokhtari K, Emile JF, Galanaud D, Belaid H, de Bernard S, Benameur N, Barlog VC, Psimaras D, Donadieu J, Carpentier C, Martin-Duverneuil N, Haroche J, Feuvret L, Zahr N, Delattre JY, Hoang-Xuan K. Idbaih A, et al. Among authors: emile jf. Neurology. 2014 Oct 14;83(16):1478-80. doi: 10.1212/WNL.0000000000000880. Epub 2014 Sep 10. Neurology. 2014. PMID: 25209580 No abstract available.
449 results